Journals / Acta Medica Anatolia / 2016 / Cilt: 4 - Sayı: 3

Screening Cytomegalovirus Infections in First Trimester of Gestation among High Prevalence Population

Pages
101–106
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although, there was no difference in terms of birth weight and gestational age at delivery, detection of primary CMV infection is associated with higher rate of spontaneous abortion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Cytomegalovirus (CMV) is known as a major cause of congenital viral infection in humans.
📊
Key Findings & Data:The aim of this study was to evaluate the rate of CMV infection and identify risk factors for infection by screening pregnant women in high prevalence population.Methods: A retrospective study was conducted between January 2014 and December 2014 in women presenting for their first antenatal visit (between 6-12 weeks of gestation).
💡
Conclusion & Impact:Although, there was no difference in terms of birth weight and gestational age at delivery, detection of primary CMV infection is associated with higher rate of spontaneous abortion.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Cytomegalovirus (CMV) is known as a major cause of congenital viral infection in humans. The aim of this study was to evaluate the rate of CMV infection and identify risk factors for infection by screening pregnant women in high prevalence population.Methods: A retrospective study was conducted between January 2014 and December 2014 in women presenting for their first antenatal visit (between 6-12 weeks of gestation). All women were tested for IgG and IgM antibodies. Subsequently, avidity test was used to discriminate between primary or non-primary CMV infection. They were followed until delivery and newborns were examined by a pediatrician.Results: A total of 3212 pregnant women were screened during the study period. The rate of seropositivity and seronegativity were found as 97.9% and 2.1% respectively. The prevalence of maternal CMV infection was found as 1.1% (34 women). Among these women, the rate of primary and recurrent CMV infection were found to be 0.3% (8 women) and 0.8% (26 women) respectively. Pregnants with primary CMV infection were referred to perinatal care unit. Pregnants with recurrent infection were followed by ultrasonography for the presence of fetal abnormalities. None of the women who completed follow-up until delivery showed gross evidence of in utero CMV transmission. Isolated IgM antibody positivity was not detected in any women.Conclusion: Seroprevalence of CMV infection is very high in our region during the pregnancy. Although, there was no difference in terms of birth weight and gestational age at delivery, detection of primary CMV infection is associated with higher rate of spontaneous abortion.

🔖

Cite This Article

USTA, A., TAŞKIN, M. İ., SANCAKLI, C. U., DALKİRAN, E. S., KILINÇ, O., DUS, E. (2016). Screening Cytomegalovirus Infections in First Trimester of Gestation among High Prevalence Population. Acta Medica Anatolia, Cilt: 4 - Sayı: 3, 101–106. https://ajindex.com/articles/142042

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Molina DM, Pal S, Kayala MA, Teng A, Kim PJ, Baldi P, et al. Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays. Vaccine. 2010;28(17):3014-24.
  2. Rodriguez GE, Adler SP. Immunoglobulin G subclass responses to cytomegalovirus in seropositive patients after transfusion. Transfusion (Paris). 1990;30(6):528-31.
  3. Sanders LA, Feldman RG, Voorhorst-Ogink MM, de Haas M, Rijkers GT, Capel PJ, et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2- mediated bacterial phagocytosis by neutrophils. Infect Immun. 1995;63(1):73-81.
  4. Mcgavran MH, Smith MG. Ultrastructural, cytochemical, and microchemical observations on cytomegalovirus (salivary gland virus) infection of human cells in tissue culture. Exp Mol Pathol. 1965;76:1-10.
  5. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355-63.
  6. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253-76.
  7. Nyholm JL, Schleiss MR. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health. 2010;2:23-35.
  8. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326(10):663-7.
  9. Stagno S, Dworsky ME, Torres J, Mesa T, Hirsh T. Prevalence and importance of congenital cytomegalovirus infection in three different populations. J Pediatr. 1982;101(6):897-900.
  10. Jacquemard F, Yamamoto M, Costa J-M, Romand S, Jaqz-Aigrain E, Dejean A, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG Int J Obstet Gynaecol. 2007;114(9):1113-21.
  11. Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353(13):1350-62.
  12. Sonoyama A, Ebina Y, Morioka I, Tanimura K, Morizane M, Tairaku S, et al. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection. J Med Virol. 2012;84(12):1928-33.
  13. Johnson JM, Anderson BL. Cytomegalovirus: should we screen pregnant women for primary infection? Am J Perinatol. 2013;30(2):121-4.
  14. Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibod